Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director

Sherry Layton, Vetanco Scientific Director, will be awarded in the 12th International Conference on Emerging Infectious Diseases

Frontiers A Role for the Non-Canonical Wnt-β-Catenin and TGF-β Signaling Pathways in the Induction of Tolerance during the Establishment of a Salmonella enterica Serovar Enteritidis Persistent Cecal Infection in Chickens

Vaccines Conference-2022, Global Conference on Vaccines Research and Development

Frontiers Development of the Tonsil Microbiome in Pigs and Effects of Stress on the Microbiome

Sherry Layton - Chief Executive Officer - Vetanco USA

Sherry Layton - Chief Executive Officer - Vetanco USA

Vaccines Conference-2022, Global Conference on Vaccines Research and Development

Diretora de Biotecnologia da Vetanco/BV Science no European Animal Microbiome Congress – O Presente Rural

PDF) Effects of Different Nutritional Zinc Forms on the Proliferation of Beneficial Commensal Microorganisms

New Trends in Vaccine Development

Frontiers Evaluation of a Novel Mucosal Administered Subunit Vaccine on Colostrum IgA and Serum IgG in Sows and Control of Enterotoxigenic Escherichia coli in Neonatal and Weanling Piglets: Proof of Concept

Frontiers Differential Effects of Bacitracin Methylene Disalicylate (BMD) on the Distal Colon and Cecal Microbiota of Young Broiler Chickens

Frontiers Differential Effects of Bacitracin Methylene Disalicylate (BMD) on the Distal Colon and Cecal Microbiota of Young Broiler Chickens